BioCentury
ARTICLE | Clinical News

AS1411: Phase IIb started

March 29, 2010 7:00 AM UTC

Antisoma began an open-label, international Phase IIb trial in about 90 AML patients in first relapse or refractory to one prior treatment. The trial will evaluate cytarabine with or without 40 or 80 ...